DISCLOSEDQuarterly
Renaissance Technologies
Allogene Therapeutics Inc · NASDAQ
2,139,328 sh · $5.2M
Filed 31 Mar 2026SEC 13Fview source
Renaissance Technologies
Allogene Therapeutics Inc · NASDAQ
2,139,328 sh · $5.2M
Two Sigma Investments
Allogene Therapeutics Inc · NASDAQ
5,375,456 sh · $13.1M
BlackRock
Allogene Therapeutics Inc · NASDAQ
16,445,682 sh · $38.3M